Headline News about Regeneron Pharmaceuticals
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
September 08, 2022
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $3,900 Today
September 02, 2022
Via Benzinga
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|